Skip to main content

A nanovehicle allows drugs to reach damaged cells and destroy them

Images

Participants

Contact

Image
Section Head of Communication & Outreach
Tel.+34 93 40 37255

TV3's "Telenotícies" programme interviewed Miguel Rovira, a PhD student at IRB Barcelona and the first author of a recent study published in the journal EMBO Molecular Medicine. In this study, the scientists designed a nano-carrier to release drugs into damaged cells.

Link to TV3

Link to TV3 (vídeo)

 

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).